{"product_id":"follistatin-344-fst-344-fs344-peptide-intelligence-monograph-fime","title":"Follistatin-344 (FST-344 \/ FS344) Peptide Intelligence Monograph | FIME","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong\u003eMyostatin \/ Activin Antagonism • Skeletal Muscle Biology • Gene-Therapy Research\u003c\/strong\u003e\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eFollistatin-344 occupies one of the most fascinating—and frequently misunderstood—areas of modern muscle biology.\u003c\/p\u003e\n\u003cp\u003eIts relationship to \u003cstrong\u003emyostatin inhibition, activin signaling, skeletal-muscle growth, reproductive endocrinology, and experimental gene therapy\u003c\/strong\u003e has generated substantial scientific interest alongside increasingly ambitious claims in the peptide marketplace.\u003c\/p\u003e\n\u003cp\u003eBut there is an important problem:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNot everything described as “Follistatin-344 evidence” studied the same intervention.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe FIME \u003cstrong\u003eFollistatin-344 Peptide Intelligence Monograph\u003c\/strong\u003e traces the science from endogenous follistatin physiology through experimental muscle-growth research and human FS344 gene-therapy studies, while examining how—and whether—those findings translate to commercially marketed FST-344 products.\u003c\/p\u003e\n\u003ch3\u003eTopics Examined\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eFollistatin, myostatin, and activin biology\u003c\/li\u003e\n\u003cli\u003eThe FST-344 \/ FS344 designation\u003c\/li\u003e\n\u003cli\u003eFS344 → FS315 processing\u003c\/li\u003e\n\u003cli\u003eSkeletal-muscle growth and hypertrophy\u003c\/li\u003e\n\u003cli\u003eMuscle mass versus functional improvement\u003c\/li\u003e\n\u003cli\u003eHuman gene-therapy research\u003c\/li\u003e\n\u003cli\u003eBodybuilding and performance claims\u003c\/li\u003e\n\u003cli\u003eReproductive and endocrine considerations\u003c\/li\u003e\n\u003cli\u003eProduct identity and manufacturing questions\u003c\/li\u003e\n\u003cli\u003eHuman safety and long-term uncertainties\u003c\/li\u003e\n\u003cli\u003eRegulatory status\u003c\/li\u003e\n\u003cli\u003eFIME evidence grading and clinical translation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe Question Behind the Monograph\u003c\/h3\u003e\n\u003cp\u003eFollistatin has \u003cstrong\u003ereal biology, compelling preclinical research, and legitimate human translational investigation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eBut how much of that evidence actually applies to the products now marketed as Follistatin-344?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThat is where this monograph begins.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eVersion 1.0 Final\u003c\/strong\u003e\u003cbr\u003ePublished by the \u003cstrong\u003eFounder’s Institute of Medicine \u0026amp; Education\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eFor professional education and scientific review. Not individualized medical advice, prescribing guidance, bodybuilding or athletic-performance guidance, or a treatment protocol.\u003c\/em\u003e\u003c\/p\u003e","brand":"Founder's Institute of Medicine \u0026 Education","offers":[{"title":"Default Title","offer_id":45385127428278,"sku":null,"price":24.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0736\/0990\/4310\/files\/ChatGPTImageAug26_2026_03_46_03PM.png?v=1787788516","url":"https:\/\/foundersinstitutemed.org\/products\/follistatin-344-fst-344-fs344-peptide-intelligence-monograph-fime","provider":"Founder's Institute of Medicine \u0026 Education","version":"1.0","type":"link"}